Clinical trial
Phase I Pharmacokinetic Trial of Curcuminoids Administered in a Capsule Formulation
NCT00027495 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Pharmacokinetic Trial of Curcuminoids Administered in a Capsule Formulation
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2001
- Completion date
- September 30, 2007
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer